Inotuzumab Ozogamicin+Standard Maintenance Therapy clinical trials

A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

This study, called ALLTogether, is for children and young adults aged 0-45 with acute lymphoblastic leukaemia (ALL). It aims to improve survival and reduce side effects by combining the best treatments from several countries and testing new approaches.